We are live on ! Find out more
AIA

Avalon Investment & Advisory Portfolio holdings

AUM $3.65B
1-Year Est. Return 0.47%
This Fund
S&P 500
This Quarter Est. Return
+7.18%
1 Year Est. Return
+0.47%
3 Year Est. Return
+93.46%
5 Year Est. Return
+123.08%
10 Year Est. Return
+366.85%
AUM
$3.56B
AUM Growth
+$188M
Cap. Flow
-$4.89M
Cap. Flow %
-0.14%
Top 10 Hldgs %
16.83%
Holding
381
New
39
Increased
144
Reduced
141
Closed
36

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$32.7M
2
CVX icon
Chevron
CVX
+$20.2M
3
DD icon
DuPont de Nemours
DD
+$20M
4
MMM icon
3M
MMM
+$18.1M
5
ABBV icon
AbbVie
ABBV
+$17.4M

Sector Composition

Rank Sector Weight
1 Financials 17.08%
2 Healthcare 15.27%
3 Technology 13.71%
4 Industrials 9.1%
5 Consumer Staples 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTE icon
176
TotalEnergies
TTE
$191B
$3.75M 0.11%
5,340,913
-648,247
-11% -$443K
CAJ
177
DELISTED
Canon, Inc.
CAJ
$3.71M 0.1%
117,222
-6,568
-5% -$208K
GPN icon
178
Global Payments
GPN
$24B
$3.7M 0.1%
29,058
+1,893
+7% +$228K
UPLD icon
179
Upland Software
UPLD
$12.6M
$3.69M 0.1%
11,407
+960
+9% +$332K
ARMK icon
180
Aramark
ARMK
$14.8B
$3.68M 0.1%
118,581
+58,706
+98% +$1.71M
TSCO icon
181
Tractor Supply
TSCO
$17.9B
$3.68M 0.1%
202,545
+184,080
+997% +$3.06M
NOMD icon
182
Nomad Foods
NOMD
$1.65B
$3.67M 0.1%
+181,032
New +$3.58M
JAZZ icon
183
Jazz Pharmaceuticals
JAZZ
$16.7B
$3.63M 0.1%
21,575
+1,794
+9% +$309K
NVS icon
184
Novartis
NVS
$293B
$3.61M 0.1%
46,779
+7,627
+19% +$564K
UL icon
185
Unilever
UL
$137B
$3.59M 0.1%
58,099
+1,829
+3% +$115K
EBIX
186
DELISTED
Ebix Inc
EBIX
$3.57M 0.1%
+45,084
New +$3.59M
LH icon
187
Labcorp
LH
$25.6B
$3.51M 0.1%
23,543
+1,649
+8% +$251K
WTM icon
188
White Mountains Insurance
WTM
$5.3B
$3.5M 0.1%
+3,743
New +$3.47M
TRU icon
189
TransUnion
TRU
$15.2B
$3.45M 0.1%
46,938
+3,290
+8% +$245K
RY icon
190
Royal Bank of Canada
RY
$294B
$3.44M 0.1%
42,932
+4,231
+11% +$332K
SUPN icon
191
Supernus Pharmaceuticals
SUPN
$2.72B
$3.42M 0.1%
67,899
+4,824
+8% +$238K
IHG icon
192
InterContinental Hotels
IHG
$23.5B
$3.35M 0.09%
50,752
+3,317
+7% +$217K
NVO
193
Novo Nordisk
NVO
$203B
$3.35M 0.09%
142,244
+43,992
+45% +$1.07M
WAL icon
194
Western Alliance Bancorporation
WAL
$8.87B
$3.34M 0.09%
58,719
+4,107
+8% +$237K
WBS icon
195
Webster Financial
WBS
$12.8B
$3.33M 0.09%
56,498
+3,949
+8% +$257K
AZN icon
196
AstraZeneca
AZN
$250B
$3.3M 0.09%
41,681
+13,138
+46% +$994K
ROKU icon
197
Roku
ROKU
$22.3B
$3.24M 0.09%
44,410
+5,621
+14% +$322K
ZION icon
198
Zions Bancorporation
ZION
$10.3B
$3.24M 0.09%
64,535
+4,449
+7% +$235K
RDS.A
199
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$3.22M 0.09%
47,245
+3,486
+8% +$233K
POST icon
200
Post Holdings
POST
$4.09B
$3.19M 0.09%
+49,788
New +$3.06M

Similar funds

Avalon Investment & Advisory's Q3 2018 Portfolio in Review

As of Q3 2018, Avalon Investment & Advisory held 381 positions worth $3.56B, up 5.6% from $3.37B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Avalon Investment & Advisory's Q3 2018 filing shows 39 new, 144 increased, 141 reduced and 36 closed positions. Its largest new stake was Lam Research: 1,607,900 shares worth $24.4M. The largest sale was Intel, an estimated $32.7M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

  • Avalon Investment & Advisory's largest Q3 2018 buy was Lam Research: 1,607,900 shares worth $24.4M.
  • Avalon Investment & Advisory added most to ExxonMobil in Q3 2018, an estimated $19.1M increase.
  • Avalon Investment & Advisory's biggest Q3 2018 reduction was Intel, cutting an estimated $32.7M.
  • Avalon Investment & Advisory fully exited Southern Company in Q3 2018, selling an estimated $15.8M.
  • Avalon Investment & Advisory's ten largest holdings make up 17% of its $3.56B portfolio in Q3 2018.
  • Avalon Investment & Advisory opened 39 new positions and closed 36 in Q3 2018.
  • Avalon Investment & Advisory's portfolio value rose 5.6% quarter-over-quarter to $3.56B.

Based on Avalon Investment & Advisory's 13F filing for Q3 2018, filed 14 Nov 2018.